LLY
Eli Lilly and CompanyClose $1018.87EOD onlyThis page reflects LLY options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Historical consensus-supported lens with full content, report chain context, and metric rail.
Outlook
Neutral with a slight bullish bias, anchored by spot at max pain ($920). Confidence: 5/10. The market is pinned near-term but shows conflicting internal signals: strong bullish flow is offset by negative GEX, suggesting underlying volatility and a lack of dealer support for a sustained rally.
Conflicts: GEX -$2.7M (trending/volatile regime), P/C OI ratio 1.35 (structural put skew), falling max pain trend.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-2.7M
DEX: +7.0M shares
Gamma flip: ~$400 (Approx — based on put OI concentration of 3,177)
NTM gamma: Gamma flip ~$400 is far below spot, indicating minimal near-the-money gamma. Dealer hedging is sparse near spot, so moves will be less dampened. A move ±2% will not trigger significant new dealer flows near-term.
IV Analysis
IV vs VIX: IV 48.4% is elevated — premium selling is attractive, but negative GEX increases risk of large moves.
Term structure: **Steep front-month decay**: 4/2 IV 52.2% → 4/10 IV 45.3% (~7 vol-pt drop). Hump at 5/1 (49.7%) likely pricing April earnings.
Skew: **Front-week calendar spread edge**: Sell high IV (52.2%) in 4/2, buy lower IV (45.3%) in 4/10.
Flow Analysis
Net premium: +$71.2M bullish; P/C vol 0.37 (extreme call volume), P/C OI 1.35 (structural put OI).
Directional prints: $1000C 4/10 vol 1,975 vs OI 183 (10.8x) — likely **bought calls** as bullish bet or hedge. $1050C 4/10 vol 4,180 vs OI 227 (18.4x) — similar bullish/hedging activity. Interpretation favors bought calls given net premium direction.
Unusual: $1100C 4/2 vol 1,305 at IV 75.0% — extremely rich vol for a weekly OTM call; could be a volatility sale or a low-probability lottery ticket.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Moderate-Weak | Buy shares at $920. | Negative GEX and falling max pain trend provide headwinds; better to sell premium against shares. |
| Short stock | Moderate | Short shares at $920. | Strong bullish flow and spot at max pain create near-term pin risk; consider pairing with a call. |
| Covered call | Moderate-Strong | Own stock, sell $960C or $1000C (4/17 or later). | Stock drifts lower (max pain trend); call premium offsets some loss. |
| Cash-secured put / put spread | Moderate | Sell $890P (4/10) or $890/$870 put spread (4/17). | Negative GEX increases odds of hitting strike; defined-risk spread preferred. |
| Long calls | Moderate-Weak | Buy $940C or $960C (4/17). | High IV (41.7%) and negative GEX make directional calls expensive; needs a strong bullish catalyst. |
| Long puts / bear put spread | Moderate-Strong | Buy $900/$880 put spread (4/17). | Aligns with negative GEX and falling max pain trend; defined risk. |
| Iron condor | Weak | e.g., $890/$870P x $960/$980C (4/17). | GEX negative AND IV > 28 → mechanically weak rating. Negative GEX regime favors directional plays, not range-bound. |
| Calendar/diagonal | Moderate-Strong | **Reverse Calendar**: Sell $920C (4/2, IV 52.2%), Buy $920C (4/10, IV 45.3%). | Pin breaks and spot moves sharply; best if spot stays near $920. |
| PMCC / LEAPS diagonal | Moderate | Buy $850C (1/15/27, IV 41.0%), Sell $960C (4/17, IV 41.7%). | Long-dated bullish thesis challenged by near-term bearish drift; capital intensive. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.